Literature DB >> 21635680

Nonoccupational postexposure prophylaxis for human immunodeficiency virus in Sub-Saharan Africa: a systematic review.

Jessica E Draughon1, Daniel J Sheridan.   

Abstract

Both HIV and sexual assault remain major public health problems in Sub-Saharan Africa. This review examines the state of the science regarding provision of non- occupational post-exposure prophylaxis following sexual assault in Sub-Saharan African countries over the last 10 years. Specifically, rates of provision of HIV nPEP, the number of patients accepting nPEP, patients' rates of completing the HIV nPEP regimen as defined by the individual studies, and patients' perceptions of HIV nPEP from qualitative data.
© 2011 International Association of Forensic Nurses.

Entities:  

Mesh:

Year:  2011        PMID: 21635680     DOI: 10.1111/j.1939-3938.2011.01104.x

Source DB:  PubMed          Journal:  J Forensic Nurs        ISSN: 1556-3693            Impact factor:   1.175


  4 in total

Review 1.  Interventions to address HIV and intimate partner violence in Sub-Saharan Africa: a review of the literature.

Authors:  Jocelyn C Anderson; Jacquelyn C Campbell; Jason E Farley
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jul-Aug       Impact factor: 1.354

2.  HIV Non-Occupational Post Exposure Prophylaxis in Nigeria: A Systematic Review of Research Evidence and Practice.

Authors:  Sorochi H Iloanusi; Osaro O Mgbere; Susan M Abughosh; Ekere J Essien
Journal:  Int J MCH AIDS       Date:  2019-11-18

3.  "Reclaiming Control" Patient Acceptance and Adherence to HIV Post-Exposure Prophylaxis Following Sexual Assault.

Authors:  Jessica E Draughon Moret; Daniel J Sheridan; Jennifer A Wenzel
Journal:  Glob Qual Nurs Res       Date:  2021-11-03

4.  Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China.

Authors:  Tongtong Liu; Xi Wang; Aixin Li; Jiangzhu Ye; Duo Shan; Guang Zhang; An Liu
Journal:  BMC Public Health       Date:  2021-06-24       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.